Clinical trial
Heparin or Enoxaparin in Patients With Cancer
NCT00004875 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00004875 |
|---|---|
| Title | Heparin or Enoxaparin in Patients With Cancer |
| Official title | Release of TFPI by Anticoagulants in Cancer Patients by Standard or LMW Heparin |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Lymphoma, Thromboembolism, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | enoxaparin, heparin |
| Enrollment | 6 |
| Start date | Jul 1, 1996 |
| Primary completion | Mar 1, 1999 |
| Completion | Mar 1, 1999 |
| First posted | Jul 26, 2004 |
| Last update posted | Feb 21, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: